Vanguard Portfolio Management
TYRA icon

Vanguard Portfolio Management’s Tyra Biosciences TYRA Stock Holding History

Vanguard Portfolio Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9M Buy
403,019
+155,749
+63% +$5.15M ﹤0.01% 2117
2026
Q1 		$9.47M Buy
+247,270
New +$8M ﹤0.01% 2131

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Vanguard Portfolio Management's TYRA Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Tyra Biosciences (TYRA) stake by 63% in Q2 2026, buying an estimated $5.15M and bringing the position to 403,019 shares worth $12.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2117.

Vanguard Portfolio Management first reported a position in TYRA in Q1 2026 and has held it in 2 quarters since. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Vanguard Portfolio Management held 403,019 shares of Tyra Biosciences worth $12.9M as of Q2 2026.
  • Vanguard Portfolio Management bought 155,749 Tyra Biosciences shares in Q2 2026, an estimated $5.15M.
  • Tyra Biosciences made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2117 holding.
  • Vanguard Portfolio Management first reported a position in Tyra Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.